AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Just-Released Guidelines: Pre-Exposure Prophylaxis Use for HIV Prevention

CDC thumbnail of prep video

Today, the U.S. Public Health Service and the Centers for Disease Control and Prevention released guidelines for the use of daily oral antiretroviral pre-exposure prophylaxis, or PrEP, for HIV infection, entitled: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 [PDF 867KB]. These guidelines provide health care providers with recommendations on…

New Guidelines Strengthen HIV Screening and Prevention for Women

Ronald Valdiserri

During this week’s observance of National Women’s Health Week, I want to highlight some important new guidelines for physicians and other healthcare providers that will help expand and improve HIV screening and prevention services for women in the United States. ACOG’s HIV Expert Work Group Releases Committee Opinions on HIV in Women Last month, the…

Updated Guidelines: Perinatal Antiretroviral Treatment

AIDS info logo

The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. For a complete preview of key updates to the guidelines, please see What’s…

Conversations from CROI 2014: Dr. Douglas Dieterich on Important Advances in Hepatitis C

Doug Dietrich and Dr. Valdiserri

At the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) , Dr. Ron Valdiserri sat down for an in-depth conversation with Dr. Doug Dieterich of the Icahn School of Medicine at Mount Sinai Hospital in New York, who made several presentations and was involved in scientific posters shared during the conference on hepatitis C mono-infection and…

Conversations from CROI 2014: Dr. Deborah Persaud Discusses Cases of Two HIV Positive Infants in Remission after Very Early Treatment

mg_persuad

Among the stories making headlines from the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston this week was the next chapter in the story of the Mississippi baby whose case Dr. Deborah Persaud shared at last year’s conference. This year, she and her colleagues shared an update on the status of that child…

NIH’s Dr. Carl Dieffenbach Shares Final Highlights from CROI 2014

BiAa_wdCQAAyw6e

As the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  drew to a close in Boston, Dr. Ron Valdiserri asked National Institutes of Health’s Dr. Carl Dieffenbach to share some final thoughts on highlights of the scientific advances presented there and how they will support efforts to improve outcomes along the HIV continuum of care. In…

Scientific Advances on the HIV Care Continuum Presented at CROI

CROI logo

Among the scientific advances highlighted at the 21st Conference of Retroviruses and Opportunistic Infections (CROI)  in Boston, Massachusetts this week were a number of new studies addressing the provision of essential care to persons living with HIV infection, including diagnosis, linkage and retention in care, initiation of antiretroviral treatment (ART), and achievement of durable viral…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 5

Ron Valdiserri and Carl Dieffenbach

At the conclusion of sessions yesterday, March 5, at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, NIH’s Dr. Carl Dieffenbach sat down with Dr. Ron Valdiserri to discuss some of the day’s scientific highlights. In their video conversation below, Dr. Dieffenbach observes that three significant advances in HIV therapies were among…

Page 3 of 21« First...2345...1020...Last »